Chemical subgroup
A16AX – Sonstige Mittel für das alimentäre System und den Stoffwechsel
13Decisions
13Patient groups
Added benefit by patient group
- Considerable1
- Minor1
- Non-quantifiable10
- Not proven1
Decisions, newest first
- 2026-01-22SephienceSepiapterinNon-quantifiable
- 2025-09-04NulibryFosdenopterinNon-quantifiable
- 2025-06-18CerdelgaEliglustatNon-quantifiable
- 2024-02-15GalafoldMigalastatNot proven
- 2023-04-06ZokinvyLonafarnibNon-quantifiable
- 2021-07-01OxlumoLumasiranNon-quantifiable
- 2020-10-15Givlaari GivosiranConsiderable
- 2019-07-04RavictiGlycerolphenylbutyratNon-quantifiable
- 2018-08-16RavictiGlycerolphenylbutyratNon-quantifiable
- 2018-04-05XermeloTelotristatethylNon-quantifiable
- 2017-01-19RevestiveTeduglutidNon-quantifiable
- 2015-10-01CerdelgaEliglustatNon-quantifiable
- 2015-02-19RevestiveTeduglutidMinor
Data status: 2026-10-29